NASDAQ:MDLN

Medline (MDLN) Stock Price, News & Analysis

Medline logo
$35.18 -0.76 (-2.11%)
As of 03:19 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Medline Stock (NASDAQ:MDLN)

Advanced

Key Stats

Today's Range
$35.10
$36.14
50-Day Range
$33.19
$48.26
52-Week Range
$32.81
$50.88
Volume
3.75 million shs
Average Volume
7.32 million shs
Market Capitalization
$46.22 billion
P/E Ratio
109.94
Dividend Yield
N/A
Price Target
$50.54
Consensus Rating
Moderate Buy

Company Overview

Medline Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

MDLN MarketRank™: 

Medline scored higher than 82% of companies evaluated by MarketBeat, and ranked 17th out of 85 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medline has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 1 strong buy rating, 22 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Medline has a consensus price target of $50.54, representing about 43.5% upside from its current price of $35.22.

  • Amount of Analyst Coverage

    Medline has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medline's stock forecast and price target.
  • Earnings Growth

    Earnings for Medline are expected to grow by 7.38% in the coming year, from $1.49 to $1.60 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medline is 110.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medline is 110.06, which means that it is trading at a more expensive P/E ratio than the Manufacturing sector average P/E ratio of about 22.12.

  • Price to Earnings Growth Ratio

    Medline has a PEG Ratio of 5.22. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medline has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.75% of the float of Medline has been sold short.
  • Short Interest Ratio / Days to Cover

    Medline has a short interest ratio ("days to cover") of 1.35, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medline has recently increased by 2.27%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Medline does not currently pay a dividend.

  • Dividend Growth

    Medline does not have a long track record of dividend growth.

  • News Sentiment

    Medline has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Medline this week, compared to 7 articles on an average week.
  • Search Interest

    Only 5 people have searched for MDLN on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Medline to their MarketBeat watchlist in the last 30 days. This is an increase of 800% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medline insiders have sold 2,053.44% more of their company's stock than they have bought. Specifically, they have bought $170,750.00 in company stock and sold $3,677,000.00 in company stock.

  • Percentage Held by Insiders

    0.81% of the stock of Medline is held by insiders.

  • Percentage Held by Institutions

    Medline has minimal institutional ownership at this time.

  • Read more about Medline's insider trading history.
Receive MDLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medline and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDLN Stock News Headlines

Head-To-Head Comparison: Medline (MDLN) and Its Competitors
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel
Medline (NASDAQ:MDLN) Insider Sells $3,677,000.00 in Stock
Head-To-Head Analysis: Medline (MDLN) vs. Its Peers
Medline (MDLN) and Its Peers Head to Head Review
See More Headlines

MDLN Stock Analysis - Frequently Asked Questions

Medline's stock was trading at $42.00 at the start of the year. Since then, MDLN stock has decreased by 16.1% and is now trading at $35.22.

Medline (NASDAQ:MDLN) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.04. Medline's quarterly revenue was up 10.7% compared to the same quarter last year.
Read the conference call transcript
.

Medline (MDLN) raised $7 billion in an IPO on Wednesday, December 17th 2025. The company issued 248,439,654 shares at a price of $26.00-$30.00 per share.

Medline's lock-up period expired on Monday, June 15th. Medline had issued 216,034,482 shares in its public offering on December 17th. The total size of the offering was $6,264,999,978 based on an initial share price of $29.00. Since the end of Medline's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Top institutional shareholders of Medline include Janus Henderson Group PLC (0.87%), WCM Investment Management LLC (0.55%), Healthcare of Ontario Pension Plan Trust Fund (0.38%) and Bessemer Group Inc. (0.27%). Insiders that own company stock include Group Vii S1 LLC Tc, Aggregator Lp Mozart II, Cp Circle Ml Holdco Gp, Llc, Carlyle Group Inc, Mozart Coinvestment Ho Carlyle, Tc Group Cayman Investment Hol, Private Ltd Gic, Andrew J Mills, Charles N Mills, Hellman & Friedman Capital Par, Douglas P Golwas and Jessi L Corcoran.
View institutional ownership trends
.

Shares of MDLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2026
Today
6/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MDLN
CIK
2046386
Web
N/A
Fax
N/A
Employees
45,000
Year Founded
1966

Price Target and Rating

High Price Target
$62.00
Low Price Target
$40.00
Potential Upside/Downside
+43.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
29 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
109.94
Forward P/E Ratio
23.61
P/E Growth
5.22
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.65
Current Ratio
4.41
Quick Ratio
2.51

Sales & Book Value

Annual Sales
$28.43 billion
Price / Sales
1.63
Cash Flow
$1.66 per share
Price / Cash Flow
21.19
Book Value
$14.68 per share
Price / Book
2.40

Miscellaneous

Outstanding Shares
1,313,690,000
Free Float
1,303,047,000
Market Cap
$46.22 billion
Optionable
N/A
Beta
N/A

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:MDLN) was last updated on 6/22/2026 by MarketBeat.com Staff.
From Our Partners